APGE
Apogee Therapeutics, Inc.NASDAQHealthcare$84.34+0.12%ClosedMarket Cap: $4.72B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
5.64
P/S
0.00
EV/EBITDA
-16.49
DCF Value
$2.00
FCF Yield
-4.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-36.8%
ROA
-27.3%
ROIC
-31.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | Infinity% | $-78.1M | $-69.4M | $-1.03 | — |
| FY 2025 | $0.00 | -Infinity% | $-285.6M | $-255.8M | $-4.22 | — |
| Q3 2025 | $0.00 | -Infinity% | $-71.3M | $-65.0M | $-1.11 | — |
| Q2 2025 | $0.00 | NaN% | $-73.2M | $-66.1M | $-1.13 | — |
| Q1 2025 | $0.00 | NaN% | $-63.1M | $-55.3M | $-0.95 | — |
| Q4 2024 | $0.00 | NaN% | $-75.9M | $-67.2M | $-1.22 | — |
| FY 2024 | $0.00 | NaN% | $-216.9M | $-182.1M | $-3.30 | — |
| Q3 2024 | $0.00 | NaN% | $-58.7M | $-49.0M | $-0.86 | — |
| Q2 2024 | $0.00 | NaN% | $-44.1M | $-33.8M | $-0.60 | — |
| Q1 2024 | $0.00 | NaN% | $-38.2M | $-32.1M | $-0.64 | — |
| Q4 2023 | $0.00 | NaN% | $-37.2M | $-31.7M | $-0.63 | — |
| FY 2023 | $0.00 | NaN% | $-93.0M | $-84.0M | $-1.66 | — |